Download PDF
Am J Perinatol
DOI: 10.1055/a-2298-5347
Original Article

Pregnancy Outcomes in Women Who Developed Elevated Blood Pressure and Stage I Hypertension after 20 Weeks Gestation

Helen Woolcock
1   Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
,
Natalia Parra
1   Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
,
Yijia Zhang
1   Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
,
Uma M. Reddy
1   Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
,
Natalie A. Bello
2   Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California
,
Eliza Miller
3   Department of Neurology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
,
Whitney A. Booker 
1   Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York-Presbyterian Hospital, New York
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective The American College of Obstetrics threshold for hypertension (≥140/90 mm Hg) differs from those of the American College of Cardiology (ACC) and the American Heart Association (AHA). It is unknown if ACC/AHA hypertension levels are associated with adverse pregnancy outcomes (APOs) after 20 weeks gestation. The purpose of this study is to analyze APOs in women with blood pressure (BP) in the elevated or stage 1 range after 20 weeks gestation.

Study Design This was a secondary analysis of the nuMoM2b prospective cohort study of 10,038 nulliparous, singleton pregnancies between 2010 and 2014. BP was measured at three visits during the pregnancy using a standard protocol. Women without medical comorbidities, with normal BP by ACC/AHA guidelines (systolic BP [SBP] < 120 and diastolic BP [DBP] < 80 mm Hg) up to 22 weeks, were included. Exposure was BP between 22 and 29 weeks gestation: normal (SBP < 120 and DBP < 80 mm Hg), elevated (SBP: 120–129 and DBP < 80 mm Hg), and stage 1 (SBP: 130–139 or DBP: 80–89 mm Hg). The primary outcome was hypertensive disorder of pregnancy (HDP) at delivery. Secondary outcomes included fetal growth restriction (FGR), placental abruption, preterm delivery, and cesarean delivery. Multivariable-adjusted odds ratio (aORs) and 95% confidence intervals (CIs) were estimated using logistic regression models.

Results Of 4,460 patients that met inclusion criteria, 3,832 (85.9%) had BP in the normal range, 408 (9.1%) in elevated, and 220 (4.9%) in stage 1 range between 22 and 29 weeks. The likelihood of HDP was significantly higher in women with elevated BP (aOR 1.71, 95%CI: 1.18,2.48), and stage 1 BP (aOR: 2.79, 95%CI: 1.84,4.23) compared to normal BP (p < 0.001). Stage 1 BP had twice odds of FGR (aOR: 2.33, 95%CI: 1.22,4.47) and elevated BP had three times odds of placental abruption (aOR: 3.03; 95%CI: 1.24,7.39).

Conclusion Elevated or stage 1 BP >20 weeks of pregnancy are associated with HDP, FGR, and placental abruption.

Key Points

  • Elevated and stage 1 BP increases risk for HDP.

  • Elevated BP increases risk for placental abruption.

  • Stage 1 BP increases risk for FGR.

Keywords

blood pressure - chronic hypertension - adverse pregnancy outcomes - preeclampsia - hypertension - American College of Cardiology - American Heart Association

Note

These findings were presented in poster format at the 43rd Annual Pregnancy Meeting, Society for Maternal-Fetal Medicine, in 2023.




Publication History

Received: 06 February 2024

Accepted: 24 March 2024

Accepted Manuscript online:
03 April 2024

Article published online:
23 April 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol 2019; 133 (01) e26-e50
    CrossrefPubMedGoogle Scholar
  • 2 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (06) 1269-1324
    CrossrefPubMedGoogle Scholar
  • 3 Whelton PK, Carey RM, Aronow WS. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (06) e13-e115
    CrossrefPubMedGoogle Scholar
  • 4 Topel ML, Duncan EM, Krishna I, Badell ML, Vaccarino V, Quyyumi AA. Estimated Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on Reproductive-Aged Women. Hypertension 2018; 72 (04) e39-e42
    CrossrefPubMedGoogle Scholar
  • 5 Bello NA, Zhou H, Cheetham TC. et al. Prevalence of Hypertension Among pregnant women when using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines and Association With Maternal and Fetal Outcomes. JAMA Netw Open 2021; 4 (03) e213808
    CrossrefPubMedGoogle Scholar
  • 6 McLaren Jr RA, Al-Kouatly HB, Minkoff H. Change in prevalence of chronic hypertension in pregnancy after the updated ACC/AHA hypertension guidelines. Pregnancy Hypertens 2022; 29: 61-63
    CrossrefPubMedGoogle Scholar
  • 7 Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 2014; 348: g2301
    CrossrefPubMedGoogle Scholar
  • 8 Panaitescu AM, Baschat AA, Akolekar R, Syngelaki A, Nicolaides KH. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound Obstet Gynecol 2017; 50 (03) 361-366
    CrossrefPubMedGoogle Scholar
  • 9 Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 2007; 52 (11) 1046-1051
    PubMedGoogle Scholar
  • 10 Greenberg VR, Silasi M, Lundsberg LS. et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am J Obstet Gynecol 2021; 224 (05) 521.e1-521.e11
    CrossrefPubMedGoogle Scholar
  • 11 Hauspurg A, Parry S, Mercer BM. et al. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. Am J Obstet Gynecol 2019; 221 (03) 277.e1-277.e8
    CrossrefPubMedGoogle Scholar
  • 12 Darwin KC, Federspiel JJ, Schuh BL, Baschat AA, Vaught AJ. ACC-AHA diagnostic criteria for hypertension in pregnancy identifies patients at intermediate risk of adverse outcomes. Am J Perinatol 2021; 38 (S 01): e249-e255
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM. Maternal outcomes associated with lower range stage 1 hypertension. Obstet Gynecol 2018; 132 (04) 843-849
    CrossrefPubMedGoogle Scholar
  • 14 Wu D-D, Gao L, Huang O. et al. Increased adverse pregnancy outcomes associated with stage 1 hypertension in a low-risk cohort: evidence from 47 874 cases. Hypertension 2020; 75 (03) 772-780
    CrossrefPubMedGoogle Scholar
  • 15 Ochsenbein-Kölble N, Roos M, Gasser T, Huch R, Huch A, Zimmermann R. Cross sectional study of automated blood pressure measurements throughout pregnancy. BJOG 2004; 111 (04) 319-325
    CrossrefPubMedGoogle Scholar
  • 16 Porcelli BA, Diveley E, Meyenburg K. et al. A new definition of gestational hypertension? New-onset blood pressures of 130 to 139/80 to 89 mm Hg after 20 weeks of gestation. Am J Obstet Gynecol 2020; 223 (03) 442.e1-44 -2.e7
    CrossrefPubMedGoogle Scholar
  • 17 Hu J, Li Y, Zhang B. et al. Impact of the 2017 ACC/AHA guideline for high blood pressure on evaluating gestational hypertension-associated risks for newborns and mothers. Circ Res 2019; 125 (02) 184-194
    CrossrefPubMedGoogle Scholar
  • 18 Liu J, Tao L, Cao Y. et al. Stage 1 hypertension defined by the 2017 American College of Cardiology/American Heart Association guideline and risk of adverse birth outcomes in Eastern China. J Hypertens 2020; 38 (06) 1090-1102
    CrossrefPubMedGoogle Scholar
  • 19 Milln J, Nakabuye B, Natamba B. et al. Adverse pregnancy outcomes associated with moderate elevations in blood pressure or blood glucose in Ugandan women; a prospective cohort study. AJOG Glob Rep 2021; 1 (02) 100007
    CrossrefPubMedGoogle Scholar
  • 20 Hauspurg A, Sutton EF, Catov JM, Caritis SN. Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension 2018; 72 (01) 202-207
    CrossrefPubMedGoogle Scholar
  • 21 Haas DM, Parker CB, Wing DA. et al; NuMoM2b study. A description of the methods of the nulliparous pregnancy outcomes study: monitoring mothers-to-be (nuMoM2b). Am J Obstet Gynecol 2015; 212 (04) 539.e1-539 -.e24
    CrossrefPubMedGoogle Scholar
  • 22 Pickering TG, Hall JE, Appel LJ. et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111 (05) 697-716
    CrossrefPubMedGoogle Scholar
  • 23 Gestational Hypertension and Preeclampsia. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135 (06) e237-e260
    CrossrefPubMedGoogle Scholar
  • 24 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics and the Society for Maternal-Fetal Medicin. ACOG Practice Bulletin No. 204: fetal growth restriction. Obstet Gynecol 2019; 133 (02) e97-e109
    Google Scholar
  • 25 American College of Obstetricians and Gynecologists, Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 127: management of preterm labor. Obstet Gynecol 2012; 119 (06) 1308-1317
    CrossrefPubMedGoogle Scholar
  • 26 Ford ND, Cox S, Ko JY. et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization—United States, 2017-2019. MMWR Morb Mortal Wkly Rep 2022; 71 (17) 585-591
    CrossrefPubMedGoogle Scholar
  • 27 Sheen JJ, Wright JD, Goffman D. et al. Maternal age and risk for adverse outcomes. Am J Obstet Gynecol 2018; 219 (04) 390.e1-390.e15
    CrossrefPubMedGoogle Scholar
  • 28 Retnakaran R, Ye C, Wen SW, Tan H. The association between pre-gravid and first trimester maternal weight and its implications for clinical research studies. Sci Rep 2022; 12 (01) 18627
    CrossrefPubMedGoogle Scholar
  • 29 Ghosh G, Grewal J, Männistö T. et al. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis 2014; 24 (03) 283-289
    PubMedGoogle Scholar
  • 30 Gyamfi-Bannerman C, Pandita A, Miller EC. et al. Preeclampsia outcomes at delivery and race. J Matern Fetal Neonatal Med 2020; 33 (21) 3619-3626
    CrossrefPubMedGoogle Scholar
  • 31 Grobman WA, Parker CB, Willinger M. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) Network*. Racial disparities in adverse pregnancy outcomes and psychosocial stress. Obstet Gynecol 2018; 131 (02) 328-335
    CrossrefPubMedGoogle Scholar
  • 32 Rosner JY, Gutierrez M, Dziadosz M. et al. Prehypertension in early versus late pregnancy. J Matern Fetal Neonatal Med 2019; 32 (02) 188-192
    CrossrefPubMedGoogle Scholar
  • 33 Reddy M, Rolnik DL, Harris K. et al. Challenging the definition of hypertension in pregnancy: a retrospective cohort study. Am J Obstet Gynecol 2020; 222 (06) 606.e1-606.e21
    CrossrefPubMedGoogle Scholar
  • 34 Mishra N, Nugent WH, Mahavadi S, Walsh SW. Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension 2011; 58 (05) 867-873
    CrossrefPubMedGoogle Scholar
  • 35 Goulopoulou S. Maternal vascular physiology in preeclampsia. Hypertension 2017; 70 (06) 1066-1073
    CrossrefPubMedGoogle Scholar
  • 36 Downes KL, Grantz KL, Shenassa ED. Maternal, labor, delivery, and perinatal outcomes associated with placental abruption: a systematic review. Am J Perinatol 2017; 34 (10) 935-957
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis. Obstet Gynecol 1996; 88 (02) 309-318
    CrossrefPubMedGoogle Scholar
  • 38 Khan S, Chughani G, Amir F, Bano K. Frequency of abruptio placenta in women with pregnancy-induced hypertension. Cureus 2022; 14 (01) e21524
    PubMedGoogle Scholar
  • 39 Allen VM, Joseph K, Murphy KE, Magee LA, Ohlsson A. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Pregnancy Childbirth 2004; 4 (01) 17
    CrossrefPubMedGoogle Scholar
  • 40 Gebb J, Dar P. Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2011; 25 (03) 355-366
    CrossrefPubMedGoogle Scholar
  • 41 Wikström A-K, Gunnarsdottir J, Nelander M, Simic M, Stephansson O, Cnattingius S. Prehypertension in pregnancy and risks of small for gestational age infant and stillbirth. Hypertension 2016; 67 (03) 640-646
    CrossrefPubMedGoogle Scholar
  • 42 Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension 2014; 64 (01) 36-44
    CrossrefPubMedGoogle Scholar
  • 43 Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
    CrossrefPubMedGoogle Scholar
  • 44 Garovic VD, Dechend R, Easterling T. et al; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease, Kidney in Heart Disease Science Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension 2022; 79 (02) e21-e41
    CrossrefPubMedGoogle Scholar
  • 45 Tita AT, Szychowski JM, Boggess K. et al; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for mild chronic hypertension during pregnancy. N Engl J Med 2022; 386 (19) 1781-1792
    CrossrefPubMedGoogle Scholar
  • 46 Society for Maternal-Fetal Medicine; Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Statement: antihypertensive therapy for mild chronic hypertension in pregnancy—the chronic hypertension and pregnancy trial. Am J Obstet Gynecol 2022; 227 (02) B24-B27
    CrossrefPubMedGoogle Scholar
  • 47 Slade LJ, Wilson M, Mistry HD. et al. The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes. Am J Obstet Gynecol 2023; 229 (02) 101-117
    CrossrefPubMedGoogle Scholar